SATS Insider Sales: Paul Orban Sells 50,062 Shares; Options at $14.04
Rhea-AI Filing Summary
Paul W. Orban, an officer of EchoStar Corporation (SATS), reported multiple transactions executed under a Rule 10b5-1 trading plan adopted December 3, 2024. On 08/29/2025 the filing shows purchases at an exercise/conversion price of $14.04 and contemporaneous sales at weighted-average prices around $61.24–$61.26. Total reported market sales on that date equal 50,062 shares (16,518 + 13,544 + 20,000) sold at weighted averages in the $60.65–$61.87 range. The report also discloses related employee stock options with a $14.04 strike and specified vesting schedules, and 744 shares held indirectly via a 401(k).
Positive
- Transactions executed under a documented Rule 10b5-1 plan, which supports orderly, pre-planned trading and reduces ambiguity about timing.
- Detailed vesting schedules and option strike price ($14.04) disclosed, improving transparency about potential future dilution and alignment with management incentives.
- Indirect holdings via 401(k) disclosed (744 shares), adding clarity on total beneficial ownership.
Negative
- Large aggregate sales of 50,062 shares on 08/29/2025 (16,518 + 13,544 + 20,000) at weighted-average prices around $61.24–$61.26 may reduce insider share count materially.
- Form reports weighted-average sale price ranges but not per-lot sale breakdowns; full per-price allocation is available only upon request to the SEC, issuer, or a security holder.
Insights
TL;DR: Officer executed sizable sales under a pre-established 10b5-1 plan while holding options with a $14.04 strike.
The Form 4 documents routine, pre-planned insider activity: purchases tied to option exercises or option-related acquisitions at a $14.04 price and near-immediate market sales at ~ $61.25 on 08/29/2025 under a 10b5-1 plan adopted December 3, 2024. The sales total 50,062 shares; the filing provides weighted-average sale price ranges but not per-lot breakdowns. Options disclosed carry a $14.04 exercise price with staggered vesting schedules. This filing is material for share-count and dilution tracking but aligns with a documented trading plan, reducing interpretive ambiguity for investors.
TL;DR: Disclosure shows compliance with Rule 10b5-1 and transparent vesting schedules, limiting governance concerns.
The report demonstrates procedural compliance: the transactions were effected pursuant to a written 10b5-1 plan and the Form 4 includes option vesting details and indirect holdings (401(k)). The presence of detailed footnotes on weighted-average sale prices and explicit vesting timetables supports transparency. There is no indication in the filing of unusual transfer methods or related-party arrangements beyond customary option grants and plan-based sales.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Class A Common Stock | 16,518 | $0.00 | -- |
| Exercise | Class A Common Stock | 13,544 | $0.00 | -- |
| Exercise | Employee Stock Option (Right To Buy) | 20,000 | $14.04 | $281K |
| Exercise | Class A Common Stock | 16,518 | $14.04 | $232K |
| Sale | Class A Common Stock | 16,518 | $61.26 | $1.01M |
| Exercise | Class A Common Stock | 13,544 | $14.04 | $190K |
| Sale | Class A Common Stock | 13,544 | $61.24 | $829K |
| Exercise | Class A Common Stock | 20,000 | $14.04 | $281K |
| Sale | Class A Common Stock | 20,000 | $61.26 | $1.23M |
| holding | Class A Common Stock | -- | -- | -- |
Footnotes (1)
- The transaction reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 3, 2024. Based on a weighted average sale price. The shares reported in this transaction were sold at prices ranging from $60.65 to $61.83. Information regarding the number of shares sold at each separate price will be made available upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer. Based on a weighted average sale price. The shares reported in this transaction were sold at prices ranging from $60.65 to $61.80. Information regarding the number of shares sold at each separate price will be made available upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer. Based on a weighted average sale price. The shares reported in this transaction were sold at prices ranging from $60.65 to $61.87. Information regarding the number of shares sold at each separate price will be made available upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer. By 401(K). 40% of the shares underlying these options vested immediately upon the grant date. The remaining 60% of the shares underlying these options vest 30% per year on each of April 1, 2025 and April 1, 2026. The shares underlying these options vest 25% per year on each of April 1, 2025, April 1, 2026, April 1, 2027 and April 1, 2028. The shares underlying the options vest at the rate of 20% per year, commencing upon April 1, 2025.
